References
- Barsan W. G., Seger D., Danzl D. F., Ling L. J., Bartlett R., Buncher R., Bryan C. Duration of antagonistic effects of nalmefene and naloxone in opiate-induced sedation for emergency department procedures. American Journal of Emergency Medicine 1989; 7(2)155–161
- Bollenbeck G. N., Long J. W., Benjamin D. G., Lindquist J. A. The synthesis of aryl-D-glucopyranosiduronic acids. Journal of the American Chemical Society 1955; 77: 3310–3315
- Dixon R., Hsiao J., Hsu H. B., Smulkowski M., Tze-Ming-Chan, Pramanik B., Morton J. Isolation of a novel morphinan 3-O-diglucuronide metabolite from dog urine. Pharmaceutical Research 1989; 6(1)28–32
- Dyson D. H., Doherty T., Anderson G. I., McDonell W. N. Reversal of oxymorphone sedation by naloxone, nalmefene and butorphanol. Veterinary Surgery 1990; 19(5)398–403
- Gal T. J., DiFazio C. A. Prolonged antagonism of opioid action with intravenous nalmefene in man. Anesthesiology 1986; 64(2)175–80
- Glass P. S., Jhaveri R. M., Smith L. R. Comparison of potency and duration of action of nalmefene and naloxone. Anesthesia Analgesia 1994; 78: 536–541
- Kaplan J. L., Marx J. A. Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study. Annals of Emergency Medicine 1993; 22(2)187–90
- Konieczko K. M., Jones J. G., Barrowcliffe M. P., Jordan C., Altman D. G. Antagonism of morphine-induced respiratory depression with nalmefene. British Journal of Anaesthesiology 1988; 61(3)318–323
- Michel M. E., Bolger G., Weissman B. A. Binding of new opiate antagonist, nalmefene to rat brain membranes. Methods and Findings in Experimental Clinical Pharmacology 1985; 7(4)175–177
- Van Vugt D. A., Webb M. Y., Reid R. L. Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of rhesus monkey. Neuroend-ocrinology 1989; 49: 275–280
- Veng-Pedersen P., Wilhelm J. A., Zakszewski T B., Osifchin E., Waters S. J. Duration of opiold antagonism by nalmefene and naloxone in the dog: an integrated phar-macokinetic/pharmacodynamic comparison. Journal of Pharmaceutical Sciences 1995; 84: 1101–1106
- Wilhelm J. A., Veng-Pedersen P., Zakszewski T. B., Osifchin E., Waters S. J. Duration of opioid antagonism by nalmefene and naloxone in the dog: a nonparametric pharmacodynamic evaluation based on generalized cross-validated spline estimation. International Journal of Clinical Pharmacology and Therapeutics 1995; 33: 540–545